Department of Biomedical Sciences, University of Padova, 35131 Padova, Italy.
Fondazione Istituto di Ricerca Pediatrica Città della Speranza, 35127 Padova, Italy.
Int J Mol Sci. 2018 Dec 27;20(1):96. doi: 10.3390/ijms20010096.
Metastasis still represents the primary cause of cancer morbidity and mortality worldwide. Chemokine signalling contributes to the overall process of cancer growth and metastasis, and their expression in both primary tumors and metastatic lesions correlate with prognosis. Chemokines promote tumor metastasization by directly supporting cancer cell survival and invasion, angiogenesis, and by indirectly shaping the pre-metastatic niches and antitumor immunity. Here, we will focus on the relevant chemokine/chemokine receptor axes that have been described to drive the metastatic process. We elaborate on their role in the regulation of tumor angiogenesis and immune cell recruitment at both the primary tumor lesions and the pre-metastatic foci. Furthermore, we also discuss the advantages and limits of current pharmacological strategies developed to target chemokine networks for cancer therapy.
转移仍然是全球癌症发病率和死亡率的主要原因。趋化因子信号转导有助于癌症生长和转移的整体过程,它们在原发性肿瘤和转移性病变中的表达与预后相关。趋化因子通过直接支持癌细胞的存活和侵袭、血管生成,以及间接塑造转移前的生态位和抗肿瘤免疫,促进肿瘤转移。在这里,我们将重点介绍已被描述为驱动转移过程的相关趋化因子/趋化因子受体轴。我们详细阐述了它们在调节原发性肿瘤病变和转移前病灶中肿瘤血管生成和免疫细胞募集中的作用。此外,我们还讨论了目前为癌症治疗而开发的靶向趋化因子网络的药理学策略的优势和局限性。